Skip to main content

Advertisement

Table 3 Number of first transfusions occurring at hemoglobin ≤8 g/dL or > 8 g/dL

From: Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

   Baseline Hemoglobin < 10 g/dL Baseline Hemoglobin ≥10 g/dL
   Darbepoetin alfa 500 mcg Q3W Darbepoetin alfa 2.25 mcg/kg QW Darbepoetin alfa 500 mcg Q3W Darbepoetin alfa 2.25 mcg/kg QW
Firsta transfusion during week 5 to EOTP Hb ≤8 g/dL, n (%) 30 (56) 29 (46) 12 (55) 12 (39)
  Hb > 8 g/dL, n (%) 24 (44) 34 (54) 10 (45) 19 (61)
Firsta transfusion during week 1 to EOTP Hb ≤8 g/dL, n (%) 42 (58) 30 (38) 9 (39) 14 (35)
  Hb > 8 g/dL, n (%) 30 (41) 48 (62) 14 (61) 24 (60)
  Hb missing, n (%) 1 (1) 0 (0) 0 (0) 2 (5)
  1. Q3W = every three weeks; QW = weekly; EOTP = end of the treatment period (defined as the earlier of day 109 or end of study); Hb = hemoglobin; n = number of transfusion events. Note that as data described are for first transfusion only, n also equals the number of patients with at least one transfusion.
  2. aThe closest hemoglobin value on the day of transfusion or within 7 days prior was used.